Pelle-926-203 Study, a research study for adults 18 years of age and older with High Frequency Basal Cell Carcinoma.

Updated on 23 November 2020


A multicenter, randomized, double-blind, vehicle-controlled, phase 2 efficacy and safety study of Patidegib Topical Gel, 2% for adults with high frequency Basal Cell Carcinoma (HF-BCC) who are 18 years of age and older at the time of study enrollment. 

The study comprises three periods: screening, treatment, and follow-up. Participation in this study will last approximately 10.5 months.


The purpose of the study is to determine the safety and effectiveness of an investigational topical gel for the reduction of facial Basal Cell Carcinomas requiring surgery in people living with HF-BCC.

Condition Basal cell carcinoma, Skin Cancer
Clinical Study IdentifierTX233893
Last Modified on23 November 2020


Yes No Not Sure

Inclusion Criteria

The subject must be at least 18 years old at the Screening Visit
The subject must have had at least 10 (with at least 3 on the face) clinically typical BCCs present within 24 months prior to Screening and Randomization (Baseline/Day 1). Additionally, the subject must have at least 2 BCCs with longest diameter < 5 mm present on the face prior to Screening and Randomization (Baseline/Day 1)
The subject must be willing to have blood collected to measure circulating drug levels
The subject must be willing to abstain from application of a non-study topical medication (prescription or over the counter) to facial skin for the duration of the trial except as prescribed by the Investigator. Moisturizers and emollients are allowed. Subjects will be encouraged to use their preferred sunscreen with a sunscreen protection factor (SPF) of at least 30, daily, on all exposed skin sites

Exclusion Criteria

The subject has been previously diagnosed with Gorlin syndrome
On medical history, family history, or clinical examination there is a suspicion that the patient has Gorlin syndrome
Patients with a family history of medulloblastoma
The subject has previously participated in a clinical trial evaluating patidegib topical gel
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact



Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note